Please assess the completion status of the following clinical trial:

Trial Title: Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients suffering from community-acquired pneumonia severe enough to require hospitalization~* Female patients must be postmenopausal for at least 1 year, surgically sterile, or practicing an effective method of birth control before entry and throughout the study~Exclusion Criteria:~* Patients with known or suspected hypersensitivity to any related antibiotic medications~* Treatment with any experimental drug within 30 days before enrollment~* Prior enrollment in this study or any study with ceftobiprole medocaril

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ceftobiprole medocaril (Type: EXPERIMENTAL): Ceftobiprole medocaril 500mg q8h as 2h infusions, 7-14d
- Ceftriaxone with or without Linezolid (Type: ACTIVE_COMPARATOR): Ceftriaxone 2g qd as 0.5h infusions with or without Linezolid 600mg q12h as 1h infusions, 7-14d

Based on this trial design, predict the completion outcome and termination type (if applicable).